T. Tognetti, A. Estevez, C.G. Luchetti, V. Sander, A.M. Franchi, A.B. Motta
{"title":"Relationship between endothelin 1 and nitric oxide system in the corpus luteum regression","authors":"T. Tognetti, A. Estevez, C.G. Luchetti, V. Sander, A.M. Franchi, A.B. Motta","doi":"10.1016/j.plefa.2003.07.002","DOIUrl":null,"url":null,"abstract":"<div><div><span><span>The present study was designed to investigate the relationship between the nitric oxide (NO) system and </span>endothelin<span><span><span><span> 1 (ET-1) in the mechanism of corpus luteum<span> (CL) development and consequently regression in rats. We first evaluated basal ET-1 levels in ovarian tissue from rats with different stages of CL development. An increased ovarian ET-1 content was found during </span></span>CL regression. In a dose-department response, ET-1 decreased </span>progesterone (P4) and increased </span>prostaglandin (PG) PGF2</span></span><em>α</em><span><span><span> production. By means of a competitive nitric oxide synthase (NOS) inhibitor: L-nitro </span>arginine methyl ester (L-NAME) and a slow NO releasing: diethyl-aminetriamine (DETA-NONOate), we demonstrated that NO system could be the intermediary in the ET-1 diminishing P4 production. The </span>Western blot analysis<span><span> revealed an increase on iNOS while </span>eNOS<span> protein expression<span><span> was diminished. We also found a diminution of total NOS activity after ET-1 treatment. These data suggest the existence of a functional relationship between ET-1 and NOS </span>isoforms leading the regulation of CL functionally.</span></span></span></span></div></div>","PeriodicalId":94179,"journal":{"name":"Prostaglandins, leukotrienes, and essential fatty acids","volume":"69 5","pages":"Pages 359-364"},"PeriodicalIF":3.2000,"publicationDate":"2003-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Prostaglandins, leukotrienes, and essential fatty acids","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0952327803001509","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The present study was designed to investigate the relationship between the nitric oxide (NO) system and endothelin 1 (ET-1) in the mechanism of corpus luteum (CL) development and consequently regression in rats. We first evaluated basal ET-1 levels in ovarian tissue from rats with different stages of CL development. An increased ovarian ET-1 content was found during CL regression. In a dose-department response, ET-1 decreased progesterone (P4) and increased prostaglandin (PG) PGF2α production. By means of a competitive nitric oxide synthase (NOS) inhibitor: L-nitro arginine methyl ester (L-NAME) and a slow NO releasing: diethyl-aminetriamine (DETA-NONOate), we demonstrated that NO system could be the intermediary in the ET-1 diminishing P4 production. The Western blot analysis revealed an increase on iNOS while eNOS protein expression was diminished. We also found a diminution of total NOS activity after ET-1 treatment. These data suggest the existence of a functional relationship between ET-1 and NOS isoforms leading the regulation of CL functionally.